Ampiclox Quick Release 75 mg/4 g - 200 mg/4 g, suspension intramammaire pour bovins
Ampiclox Quick Release 75 mg/4 g - 200 mg/4 g, suspension intramammaire pour bovins
Authorised
- Ampicillin
- Cloxacillin
Product identification
Medicine name:
Ampiclox Quick Release 75 mg/4 g - 200 mg/4 g, suspension intramammaire pour bovins
Active substance:
- Ampicillin
- Cloxacillin
Target species:
-
Cattle
Route of administration:
-
Intramammary use
-
Intramammary use
Product details
Active substance and strength:
-
Ampicillin75.00/milligram(s)1.00Tube
-
Cloxacillin200.00/milligram(s)1.00Tube
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle
-
Meat and offal2day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51CF02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Luxembourg
Available in:
-
Luxembourg
Package description:
- Ampiclox Quick Release 3 4 g Tube Intramammary suspension
- Ampiclox Quick Release 12 4 g Tube Intramammary suspension
- Ampiclox Quick Release 24 4 g Tube Intramammary suspension
- Ampiclox Quick Release 30 4 g Tube Intramammary suspension
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
- Haupt Pharma Latina S.r.l.
Responsible authority:
- Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
- V 087/93/03/0392
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 2/02/2023